YisP is an enzyme involved in the pathway of biofilm formation in bacteria and is predicted to possess squalene synthase activity. A BlastP search using the YisP protein sequence from Bacillus subtilis subsp. subtilis strain 168 shows that it shares 23% identity with the dehydrosqualene synthase from Staphylococcus aureus. The YisP from B. subtilis 168 was expressed in Escherichia coli and the recombinant protein was purified and crystallized. The crystals, which belong to the orthorhombic space group P2 1 2 1 2 1 , with unit-cell parameters a = 43.966, b = 77.576, c = 91.378 Å , were obtained by the sitting-drop vapour-diffusion method and diffracted to 1.92 Å resolution. Structure determination using MAD and MIR methods is in progress.
Introduction
Eukaryotic cells possess microdomains called lipid rafts on the cell surface, regions where signalling and transport proteins are enriched to enhance their functions. Recently, it has been found that bacteria also contain such microdomains that are functionally similar to those of eukaryotic cells, and a squalene synthase inhibitor, zaragozic acid, can interfere with lipid raft formation. Through bioinformatics analysis of the Bacillus subtilis genome, a nonessential gene, yisP (GenBank accession No. NC_000964.3), has been found to participate in squalene synthesis (Ló pez & Kolter, 2010) . The gene product, YisP (274 residues; Pfam ID PF00494), has sequence similarity to phytoene synthase or squalene synthase and is also inhibited by zaragozic acid (Kobayashi et al., 2003) . The deletion of yisP resulted in a complete loss of pellicle formation ability.
The dehydrosqualene synthase from Staphylococcus aureus (SaCrtM) and human squalene synthase (hSQS) have been purified and characterized (Liu et al., 2008; Pandit et al., 2000) . CrtM catalyses the initial step in the biosynthesis of staphyloxanthin in most staphylococci strains and SQS is involved in the biosynthesis of sterols in eukaryotes. SaCrtM and hSQS share similar structures and both are inhibited by zaragozic acid (Liu et al., 2012) . YisP is predicted to have squalene synthase activity and to play a role in the bacteria biofilm formation pathway, which is also inhibited by zaragozic acid. Most YisP have two conserved DXXXD motifs, which interact with the substrate through a metal-mediated interaction (Liu et al., 2008 (Liu et al., , 2012 . However, YisP from B. subtilis subsp. subtilis strain 168 (BsYisP) only possesses the second DXXXD motif and does not have the first one ( Fig. 1 ). BsYisP shares 27% and 11% amino-acid identity with SaCrtM and hSQS, respectively. Because of the lack of the first DXXXD motif, it will be very interesting to investigate the effects of this missing motif on the squalene synthase activity of BsYisP. Furthermore, structural information is of great importance to further understand YisP function and the mechanism of bacterial biofilm synthesis.
Materials and methods

Protein preparation
The gene encoding BsYisP (GenBank accession No. NC_000964.3) from B. subtilis 168 was amplified by polymerase chain reaction (PCR) with the forward primer 5 0 -GGTATTGAGGGTCGCGCTG-GTGCTGGTGCTATGATACATAGGAGTGAGAAAATG-3 0 and the reverse primer 5 0 -AGAGGAGAGTTAGAGCCGTTAGATAT-CAGACAGAATCTGCTT-3 0 , and then cloned into the pET32 Xa/LIC vector. The recombinant plasmid was transformed into Escherichia coli BL21trxB (DE3) and the protein was induced with 0.5 mM isopropyl -d-1-thiogalactopyranoside (IPTG) at 293 K for 24 h.
Cell pellets were harvested by centrifugation at 6000g and resuspended in lysis buffer consisting of 25 mM Tris-HCl pH 8.5, 150 mM NaCl, 20 mM imidazole. The cell lysate was prepared with a French press (JNBIO JN-3000PLUS) and then centrifuged at 17 000g to remove cell debris. The protein was purified with an Ä KTApurifier 10 (GE Healthcare Life Sciences) using an Ni-NTA column. The buffer used for the Ni-NTA column was 25 mM Tris-HCl pH 8.5, 150 mM NaCl, 20 mM imidazole. BsYisP protein was eluted at about 150 mM imidazole when using a 20-250 mM imidazole gradient. The protein was dialysed against buffer consisting of 25 mM Tris-HCl pH 8.5, 150 mM NaCl and then subjected to factor Xa digestion at 277 K for 48 h to remove the tag. The buffer for digestion contained 50 mM Tris-HCl pH 8.0, 100 mM NaCl, 5 mM CaCl 2 and the ratio of factor Xa to BsYisP was 0.2 U mg À1 . The vector-derived peptide sequence AGAGA was left at the N-terminus after digestion. The mixture was then passed through another Ni-NTA column and subsequently untagged BsYisP was eluted with 5 mM imidazole-containing buffer and then dialysed twice against 5 l buffer (25 mM Tris-HCl pH 8.5, 150 mM NaCl) for storage. All purification procedures were performed at 293 K and the yield of BsYisP was about 3 mg l À1 . SDS-PAGE analysis was used to check the purity (>95%) of BsYisP. Expression of selenomethionine-substituted (SeMet) BsYisP was conducted based on the method of Van Duyne et al. (1993) . The purification procedures and the factor Xa cleavage were the same as those described for the wild-type enzyme. The yield of SeMet BsYisP was about 2 mg l À1 after purification. The native and SeMet proteins (31.8 kDa; amino acids 1-279 with AGAGA remaining at the Nterminus from the His-tag) were concentrated to 10 mg ml À1 in 25 mM Tris-HCl pH 8.5, 150 mM NaCl using an Amicon Ultra-15 Centricon (Millipore).
Crystallization and data collection
Initial crystallization screening was performed manually using 768 different reservoir conditions from Hampton Research (Laguna Niguel, California, USA) kits, including Crystal Screen, Crystal Screen 2, Crystal Screen Cryo, Crystal Screen Lite, MembFac, Natrix, Index, SaltRx, SaltRx 2, PEG/Ion, PEG/Ion 2, Quik Screen and Grid Screens (ammonium sulfate, MPD, sodium chloride, sodium malonate, PEG 6000 and PEG/LiCl) with the sitting-drop vapour-diffusion method. In general, 1 ml of BsYisP-containing solution (25 mM Tris-HCl pH 8.5, 150 mM NaCl) was mixed with 1 ml reservoir solution in 24-well Cryschem Plates (Hampton Research) and equilibrated against 300 ml reservoir solution at 278 K. The initial crystals of BsYisP were obtained within 2 d using Grid Screen PEG/LiCl condition C6 [1 M LiCl, 0.1 M Bicine pH 9.0, 20%(w/v) polyethylene glycol 6000]. The optimized crystallization condition for all crystals mentioned here was modified to 1 M LiCl, 0.1 M Bicine pH 9.0, 18-20%(w/v) polyethylene glycol 6000. An X-ray diffraction data set was collected to 1.92 Å resolution (based on the criterion of keeping the merging R factor below 0.5 in the highest-resolution shell) on beamline BL13B1 of the National Synchrotron Radiation Research Center (NSRRC; Hsinchu, Taiwan). The diffraction images were processed using the program HKL-2000 (Otwinowski & Minor, 1997) . Data-collection statistics are shown in Table 1 .
Results and discussion
As shown in Fig. 2 , the BsYisP crystal reached dimensions of about 0.1 Â 0.1 Â 0.3 mm within 2-3 d. Prior to data collection at 100 K, the crystal was mounted in a cryoloop and flash-cooled in liquid nitrogen with a slightly modified cryoprotectant, which consisted of 0.1 M Bicine, pH 9.0, 1 M LiCl, 23%(w/v) polyethylene glycol 6000 and 12% glycerol. Based on the diffraction pattern (Fig. 3 crystal belongs to the orthorhombic space group P2 1 2 1 2 1 , with unitcell parameters a = 43.966, b = 77.576, c = 91.378 Å . Assuming the presence of one molecule per asymmetric unit, the Matthews coefficient V M (Matthews, 1968 anomalous diffraction (MAD) and preparation of crystals of heavyatom derivatives for the multiple isomorphous replacement (MIR) method are in progress.
Figure 2
A crystal of BsYisP. The crystal reached approximate dimensions of 0.1 Â 0.1 Â 0.3 mm in 3 d.
Figure 3
A diffraction pattern of the BsYisP crystal. 
